A larger processing window will account for the lot to lot changes between materials, without having to make process changes.3 Setting the Beginning Variables • Injection Pressure = Maximum of machine - Should not be pressure limited • Injection Velocity = Maximum of machine - This is for the injection velocity curve starting point - If flashing is an issue start slower and then increase • Injection Cut-Off Time = 15 seconds - This is only a limiting factor, needs to be above 10 seconds for velocity graph • Hold Pressure = 0 - Need to get 95% full part with a hold pressure of 0 • Hold Time = 10-15 seconds - Need to ensure gate is frozen • Screw Speed = 90% of Maximum - Unless shear sensitive material, if shear sensitive, set RPMs to optimum • Cooling Time = 10–15 seconds • Shot Size = 50% of calculated part volume • Decompression = .25" • Transfer Position = High enough to ensure a cushion - Cushion size does not matter but there must be a cushion to keep a constant pressure on the melt during hold time - Typically 0.25" is sufficient • Back Pressure = 800-1000 plastic pressure - 100–150 hydraulic pressure - Unless specified by material data sheet Determining Shot Size The shot size should be determined by calculating the combined volume of the parts and the runner system. If the material is shear-sensitive, consult the material data sheet or processing guide for instructions to set recovery time • The cooling time should only be 1–2 seconds longer than the screw recovery time, unless dictated by dimensional stability or part thickness Minimize Clamp Pressure This step is done to reduce the amount of energy used by the machine Shot Size = 1.00 + .10 = 1.10, Transfer Position = .50 + .10 = .60 Set Safeties This step is to ensure the machine will alarm and alert nearby employees if the machine malfunctions, or if a part gets stuck

Bob Patterson Chairman, President, and CEO August 1, 2020 SAFETY & HEALTH POLICY Avient Corporation believes safety and health are the highest corporate priority. As a member of the American Chemistry Council, we have adopted Responsible Care® Guiding Principles and the Process Safety Management Practices to guide our efforts in continuous improvement in safety performance. Our commitment to excellence in safety and health is absolute.

Microsoft Word - EHS Committee Charter (Amended July 2022).doc AVIENT CORPORATION ENVIRONMENTAL, HEALTH AND SAFETY COMMITTEE CHARTER Membership • Members of the Environmental, Health and Safety Committee (the “Committee”) of the Board of Directors (the “Board”) of Avient Corporation (the “Company”) will be appointed by the Board each year Duties and Responsibilities The Committee will: Assessment Process • Periodically review the results of formal assessments by management of the environmental liabilities for which the Company has known or probable environmental exposure and the adequacy of the Company’s financial reserves for environmental liabilities; • Semi-annually review the status of health and safety performance of the Company; • Semi-annually review the status of the Company’s product stewardship programs and performance; • Periodically review the Company’s staffing for its environmental, health and safety assessments and compliance; and 2 • Periodically review new environmental, physical security, health and safety laws and regulations applicable to the Company’s operations and issues or significant developments arising from pending regulatory and citizen group activities. Compliance Programs • At least annually review the programs and procedures established by the Company that monitor compliance with the Company’s policies, standards and practices, and laws and regulations with respect to safety, health, environmental, physical security and product stewardship, including providing oversight of the systems that are in place to monitor and mitigate the Company’s carbon footprint and physical risks associated with climate change; • Periodically review with management the significant safety, health, environmental, physical security, and product stewardship risks or exposures faced by the Company, if any, and steps taken by management to minimize such risks and exposures to the Company and its constituencies; • At least annually review the status of the Company’s environmental and safety audit process, assessing compliance with Company policies, standards, practices, laws and regulations; and • Periodically review claims, demands, administrative orders and legal proceedings against the Company regarding safety, health, environmental, physical security and product stewardship matters.

Demand conditions were robust in the quarter, in particular for composite technologies and new business gains in healthcare applications. 2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. 9 Attachment 4 Condensed Consolidated Balance Sheets (Unaudited) March 31, 2021 2020 ASSETS Current assets: Cash and cash equivalents $ 594.5 $ 649.5 Accounts receivable, net 642.2 516.6 Inventories, net 357.0 327.5 Other current assets 122.7 108.5 Total current assets 1,716.4 1,602.1 Property, net 675.5 694.9 Goodwill 1,281.9 1,308.1 Intangible assets, net 973.3 1,008.5 Operating lease assets, net 80.9 80.9 Other non-current assets 181.4 176.0 Total assets $ 4,909.4 $ 4,870.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 18.8 $ 18.6 Accounts payable 529.6 471.7 Current operating lease obligations 24.3 25.1 Accrued expenses and other current liabilities 290.9 285.6 Total current liabilities 863.6 801.0 Non-current liabilities: Long-term debt 1,852.7 1,854.0 Pension and other post-retirement benefits 111.3 115.0 Non-current operating lease obligations 56.8 56.0 Other non-current liabilities 303.0 332.8 Total non-current liabilities 2,323.8 2,357.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,707.0 1,697.1 Noncontrolling interest 15.0 14.6 Total equity 1,722.0 1,711.7 Total liabilities and equity $ 4,909.4 $ 4,870.5 10 Attachment 5 Condensed Consolidated Statements of Cash Flows (Unaudited) March 31, 2021 2020 Operating Activities Net income $ 79.7 $ 32.8 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 36.6 19.9 Accelerated depreciation and amortization 0.5 — Share-based compensation expense 2.7 2.1 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (137.6) (56.9) Increase in inventories (35.1) (13.0) Increase in accounts payable 67.3 44.6 Decrease in pension and other post-retirement benefits (7.1) (3.2) Increase in post-acquisition earnout liabilities — 1.0 Decrease in accrued expenses and other assets and liabilities, net (3.4) (19.1) Payment of post-acquisition date earnout liability — (21.0) Net cash provided (used) by operating activities 3.6 (12.8) Investing activities Capital expenditures (16.5) (11.1) Net proceeds from divestiture — 7.1 Net proceeds (used) provided by other assets (2.0) 5.2 Net cash (used) provided by investing activities (18.5) 1.2 Financing activities Purchase of common shares for treasury (4.2) (13.6) Cash dividends paid (19.5) (15.6) Repayment of long-term debt (2.3) (2.0) Payments of withholding tax on share awards (3.1) (1.3) Equity offering proceeds, net of underwriting discount and issuance costs — 496.3 Payment of acquisition date earnout liability — (32.9) Net cash (used) provided by financing activities (29.1) 430.9 Effect of exchange rate changes on cash (11.0) (3.8) (Decrease) increase in cash and cash equivalents (55.0) 415.5 Cash and cash equivalents at beginning of year 649.5 864.7 Cash and cash equivalents at end of period $ 594.5 $ 1,280.2 11 Attachment 6 Business Segment Operations (Unaudited) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe. Technical Data Sheets Safety Data Sheets

Solutions that Support the Circular Economy REDUCED ENERGY USE CESA™ Dry Additives CESA™ Release Additives OnCap™ CTR Process Optimization ColorMatrix™ Joule™ & Smartheat™ Infrared Absorber Specialty Low Cure Inks SiteCool™ Infrared Absorption Technologies BIO-DERIVED CONTENT reSound™ OM Bio-Derived Thermoplastic Elastomers reFlex™ Bio-Derived Plasticizer OnCap™ Bio Additives OnColor™ Bio Colorants reSound™ Natural Fiber Reinforced Formulations LIGHTWEIGHTING Glasforms™ Pultrusion Technologies Polystrand™ Continuous Fiber Composites IMPROVED RECYCABILITY CESA™ IR Black Additives CESA™ Extend Additives ColorMatrix™ Lactra™ SX Light Blocking Additive for PET ColorMatrix™ Ultimate™ UV Light Barrier ColorMatrix™ Capture™ Oxygen Scavenger for PET ColorMatrix™ Triple A™ Acetaldehyde Scavenging Additives ColorMatrix™ Reprize™ IV Builder for PET OnColor™ IR Sortable Black for Recyclable Packaging Bergadur™ Post-Industrial Recycled Content Polyester Formulations Nymax™ PIR Post-Industrial Recycled Nylon Formulations Maxxam™ FR Flame Retardant Polyolefin Formulations Predictions Gartner predicts circular economies will replace linear economies in 10 years, noting that supply chain leaders must adapt to circular models in order to keep up in a marketplace with a growing emphasis on sustainability.